Researchers funded by The Terry Fox Foundation and the Canadian Cancer Society have found that a cancer-fighting virus called VSV kills the most malignant form of brain cancer in mice.
The team also discovered that the virus can be given intravenously and targets invasive tumour cells.
The research team first modified the virus by altering one of the genes to make it safer in normal cells but still able to kill cancer cells. They then used a new way of delivering the virus – intravenously instead of directly into the tumour – and were able to target the main tumour as well as the tumour cells that had spread from the main mass.
The study was led by Dr. Peter Forsyth, a medical oncologist with the Alberta Cancer Board and a professor of oncology, neurosciences, biochemistry and molecular biology at the University of Calgary. The study is published in the Nov. 1 issue of the Journal of the National Cancer Institute.
The brain tumour cells that invade into the surrounding normal brain are usually "hidden" from current treatments and are the ones that usually lead to a disease recurrence. The research using the vesicular stomatitis virus (VSV) was conducted on mice as well as on tumour specimens from patients with an aggressive form of brain cancer called malignant glioma.
"These findings are an excellent example of the great value of scientific collaboration," says Darrell Fox, national director of The Terry Fox Foundation. "Dr. Forsyth is part of a pioneering group of researchers that are sharing their expertise and benefiting from the knowledge of others working in this exciting new area of anti-cancer treatment."
"Research into viruses that target cancer is a promising new avenue in the fight against this disease," says Dr. Barbara Whylie, CEO of the Canadian Cancer Society. "We look forward to the possibility of this research leading to more effective treatments for this devastating disease."
Despite dramatic advances in the treatment of malignant glioma, one of the most common types of nervous system cancers in adults, the prognosis of patients has not improved substantially in the past 30 years. While there is typically initial success in treatment, the cancer cells usually spread beyond the main tumour and the disease recurs in another part of the body. When this happens, the disease often becomes resistant to standard chemotherapy treatment.
"An ideal cancer-fighting virus should have effective delivery into multiple sites within the tumour, evade the body's immune responses, reproduce rapidly, spread within the tumour and infect cells that have spread. In this study, that's exactly what we found that VSV has done when injected intravenously," says Dr. Forsyth.
The researchers tested VSV on 14 cell lines of malignant glioma and found that the virus infected and killed all cell lines. The normal cell lines – those that did not contain malignant glioma cells – were not affected.
"One of the limitations to the use of these viruses in patients is the difficultly in getting a sufficient amount of virus to the cancer," says Dr. Forsyth. "While these are very early results, we are very encouraged to find that delivering VSV intravenously attacks the cancer cells and not normal cells. From a patient's point of view, it is obviously a lot easier to be treated with a few intravenous treatments rather than having several surgeries to inject the treatment directly into your brain."
In 2006, an estimated 2,500 Canadians will be diagnosed with brain cancer and 1,670 will die of it. Even with the best available treatments – usually surgery and chemotherapy or radiation – patients with malignant glioma survive, on average, just one year.
Bacteria as pacemaker for the intestine
22.11.2017 | Christian-Albrechts-Universität zu Kiel
Researchers identify how bacterium survives in oxygen-poor environments
22.11.2017 | Columbia University
The WHO reports an estimated 429,000 malaria deaths each year. The disease mostly affects tropical and subtropical regions and in particular the African continent. The Fraunhofer Institute for Silicate Research ISC teamed up with the Fraunhofer Institute for Molecular Biology and Applied Ecology IME and the Institute of Tropical Medicine at the University of Tübingen for a new test method to detect malaria parasites in blood. The idea of the research project “NanoFRET” is to develop a highly sensitive and reliable rapid diagnostic test so that patient treatment can begin as early as possible.
Malaria is caused by parasites transmitted by mosquito bite. The most dangerous form of malaria is malaria tropica. Left untreated, it is fatal in most cases....
The formation of stars in distant galaxies is still largely unexplored. For the first time, astron-omers at the University of Geneva have now been able to closely observe a star system six billion light-years away. In doing so, they are confirming earlier simulations made by the University of Zurich. One special effect is made possible by the multiple reflections of images that run through the cosmos like a snake.
Today, astronomers have a pretty accurate idea of how stars were formed in the recent cosmic past. But do these laws also apply to older galaxies? For around a...
Just because someone is smart and well-motivated doesn't mean he or she can learn the visual skills needed to excel at tasks like matching fingerprints, interpreting medical X-rays, keeping track of aircraft on radar displays or forensic face matching.
That is the implication of a new study which shows for the first time that there is a broad range of differences in people's visual ability and that these...
Computer Tomography (CT) is a standard procedure in hospitals, but so far, the technology has not been suitable for imaging extremely small objects. In PNAS, a team from the Technical University of Munich (TUM) describes a Nano-CT device that creates three-dimensional x-ray images at resolutions up to 100 nanometers. The first test application: Together with colleagues from the University of Kassel and Helmholtz-Zentrum Geesthacht the researchers analyzed the locomotory system of a velvet worm.
During a CT analysis, the object under investigation is x-rayed and a detector measures the respective amount of radiation absorbed from various angles....
The quantum world is fragile; error correction codes are needed to protect the information stored in a quantum object from the deteriorating effects of noise. Quantum physicists in Innsbruck have developed a protocol to pass quantum information between differently encoded building blocks of a future quantum computer, such as processors and memories. Scientists may use this protocol in the future to build a data bus for quantum computers. The researchers have published their work in the journal Nature Communications.
Future quantum computers will be able to solve problems where conventional computers fail today. We are still far away from any large-scale implementation,...
15.11.2017 | Event News
15.11.2017 | Event News
30.10.2017 | Event News
22.11.2017 | Business and Finance
22.11.2017 | Physics and Astronomy
22.11.2017 | Physics and Astronomy